FF Principal Investigator/Program Director (Last, first, middle): LYERLY. M.D . HFRBFRT KIM 
8. Lyerly HK, Matthews TJ, Langlois AJ, Bolognesi DP, Weinhold KJ: HIV GP1 
20 serves as a target for antibody dependent cellular cytotoxicity. Human Retroviruses, 
Cancer and AIDS 71:229, 1987. 
9. Lyerly HK, Reed DL, Matthews TJ, Langlois AJ, Aheame PA, Petteway SR Jr, Weinhold 
KJ: Anti-GP 20 antibodies from HIV seropositive individuals mediate broadly reactive anti- 
HTV ADCC, AIDS Research & Human Retroviruses 3940:409-22, 1987. 
10. Weinhold KJ, Lyerly HK, Matthews TJ, Tyler DS, Aheame PM, Stine KC, Langlois AJ, 
Durack DT, Bolognesi DP: Cellular anti-GP 20 cytolytic reactivities in HTV-1 seropositive 
individuals. Lancet l(8591):902-5, 1988 Apr 23. 
1 1 . Skinner MA, Ting R, Langlois AJ, Weinhold KJ, Lyerly HK, Javaherian K, Matthews TJ: 
Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. 
AIDS Research & Human Retroviruses. 4(3): 187-97, 1988 Jun. 
12. Aheame PM, Matthews TJ, Lyerly HK, White GC, Bolognesi DP, Weinhold KJ: Cellular 
immune response to viral peptides in patients exposed to HTV. AIDS Research & Human 
Retroviruses 4(4):259-67, 1988 Aug. 
13. Lyerly HK, Skinner MS, Tyler DS, Nastala CL, Matthews TJ, Bolognesi DP, Weinhold 
KJ: Anti-HIV immune cytolysis is independent of viral envelope glycosylation. Surgical 
Forum 39:420, 1988. 
14. Tyler DS, Nastala CL, Stanley SD, Matthews TJ, Lyerly HK, Bolognesi DP, Weinhold 
KJ: GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for 
circulating CD 16+ effector cells armed in vivo with cytophilic antibody. J Immunol 
142(4): 1 177-82, 1989 Feb 15. 
15. Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP: HIV-1 
GP 120-media ted immune suppression and lymphocyte destruction in the absence of viral 
infection. J Immunol 142(9):3091-7, 1989 May 1. 
16. Tyler DS, Stanley SD, Nastala CA, Austin AA, Bartlett JA, Stine KC, Lyerly HK, 
Bolognesi DP, Weinhold KJ: Alterations in antibody-dependent cellular cytotoxicity during 
the course of HIV- 1 infection. Humoral and Cellular Defects. J Immunol 144(9):3375-84, 
1990 May 1. 
17. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR: Identification of the envelope V3 loop is the 
primary determinant of cell tropism in HIV-1. Science. 253(5015):71-4, 1991. 
18. Boyle TJ, Chen H, Tamburini M, Lyerly HK: Molecular analysis of macrophage infection 
by HIV-1. Surgical Forum 42:454, 1991. 
19. Boyle TJ, Coles RE, Kizilbash AM, Lyerly HK: Effects of cyclosporine on human B-cell 
lymphoma development in vivo. J Surgical Oncology 1:89, 1992. 
20. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR: Identification of the Envelope V3 Loop as 
the Major Determinant of CD4 Neutralization Sensitivity of HIV-1. Science 257:535- 
7,1992.. 
21. Chen H, Boyle TJ, Malim MH, Cullen BR, Lyerly HK: Derivation of a Biologically 
Contained Replication System for HTV-1. Proc Natl Acad Sci USA 89(16):7678-82,1992. 
22. Boyle TJ, Tamburini M, Berend K, Kizilbash AM, Lyerly HK: Human B-cell lymphoma 
in severe combined immunodeficient mice after active infection with Epstein-Barr Virus. 
Surgery 112(2): 178-86 1992 Aug. 
23. Coles RE, Boyle TJ, Kurtzberg J, Stewart A, Peters WP, Lyerly HK: Retroviral Gene 
Transduction of Circulating Progenitor Cells in Patients with Cancer. Surgical Forum 
43:478-81, 1992. 
24. Malim MH, Freimuth WW, Liu J, Boyle TJ, Lyerly HK, Cullen BR, Nabel GJ: Stable 
Expression of Transdominant Rev Protein in Human T-cells Inhibits HIV Replication. J. 
Exp. Med 176:1197-1201, 1992. 
25. Boyle TJ, Coles RE, DiMaio JM, Berend KR, Via DF, Lyerly HK: Adoptive Transfer of 
Cytotoxic T Lymphocytes for the Treatment of Transplant Associated Lymphoma. Surgery 
1 14(2):218-226, 1993. 
26. Coles RE, Boyle TJ, Kurtzberg J, Stewart A, Peters WP, Lyerly HK: Retroviral Gene 
Transduction of Circulating Progenitor Cells in Patients with Metastatic Breast Cancer. 
Journal of Surgical Oncology 2:1-6, 1993. 
[274] 
Recombinant DNA Research, Volume 20 
